The purpose of this study is to determine the optimal dose of AD-211 in patients with osteoarthritis of the knee.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline in 100 mm Pain VAS score during activity over the past 24 hours in the target knee
Timeframe: Baseline to Week13